We are delighted to announce that Light Touch Clinic has been named Best Independent Aesthetics Clinic 2025, Weybridge, at the Global Health & Pharma (GHP) Awards.
This recognition celebrates our long-standing commitment to exceptional patient care, natural-looking results, and clinical excellence within the aesthetics industry.
“This recognition reflects our team’s dedication, expertise, and unwavering commitment to safety and ethical, high-quality care. It also reassures our patients that they are choosing a clinic known for exceptional standards and consistent results. As PM, my focus remains patient-centred with meticulous attention to safety, comfort and personalisation.
I’m equally thrilled that we’ve reached 180 Google Reviews, showcasing the trust and positive experiences of our patients. Thank you to our fantastic team, our Medical Director, Dr Natalie Geary, and most importantly, our clients and patients for your ongoing support.” — Selma Van Den Bosch, Clinic Manager
About the Global Health & Pharma Awards
The Global Health & Pharma Awards recognise outstanding leaders across the health and wellness sectors. Winning this award reflects the dedication, expertise, and safety-driven ethos upheld by our practitioners, as well as the trust placed in us by patients throughout Weybridge and Surrey.
What This Award Means for Our Patients
For our patients, this award represents reassurance that they are choosing a clinic recognised for its high standards, ethical approach, and consistent results.
From advanced skin rejuvenation to medical-grade body treatments, every service we provide is delivered with meticulous attention to safety, comfort, and personalisation.
A Thank You to Our Patients & Team
We are deeply grateful to our patients for their continued loyalty and confidence in our work. Our team’s dedication, compassion, and pursuit of excellence remain at the heart of everything we do, and this award is a reflection of their hard work.
Thank you for being part of our journey.
We are looking forward to continuing to provide the highest standard of care in 2026 and beyond.
